2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理

2022-04-26 国际多学科专家小组(统称) Mil Med Res

肉芽肿性小叶性乳腺炎(GLM)是一种罕见的慢性乳腺良性炎症性疾病,当前GLM的临床管理存在一些困难。本文主要针对GLM的管理提供共识建议。

中文标题:

2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理

英文标题:

Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)

发布日期:

2022-04-26

简要介绍:

肉芽肿性小叶性乳腺炎(GLM)是一种罕见的慢性乳腺良性炎症性疾病,当前GLM的临床管理存在一些困难。本文主要针对GLM的管理提供共识建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=db6c71c002a245d7, title=2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理, enTitle=Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition), guiderFrom=Mil Med Res, authorId=0, author=, summary=肉芽肿性小叶性乳腺炎(GLM)是一种罕见的慢性乳腺良性炎症性疾病,当前GLM的临床管理存在一些困难。本文主要针对GLM的管理提供共识建议。, cover=https://img.medsci.cn/20220428/1651113052356_1608702.png, journalId=0, articlesId=null, associationId=2667, associationName=国际多学科专家小组(统称), associationIntro=国际多学科专家小组(统称), copyright=0, guiderPublishedTime=Tue Apr 26 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">肉芽肿性小叶性乳腺炎(GLM)是一种罕见的慢性乳腺良性炎症性疾病,当前GLM的临床管理存在一些困难。本文主要针对GLM的管理提供共识建议。</span></p>, tagList=[TagDto(tagId=20598, tagName=乳腺炎), TagDto(tagId=119938, tagName=肉芽肿性小叶性乳腺炎)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20002, appHits=112, showAppHits=0, pcHits=512, showPcHits=19886, likes=5, shares=23, comments=4, approvalStatus=1, publishedTime=Thu Apr 28 15:26:00 CST 2022, publishedTimeString=2022-04-26, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Apr 28 10:28:59 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 10:12:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理.pdf)])
2021 国际多学科共识:肉芽肿性小叶性乳腺炎的管理.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232794, encodeId=1a7b1232e948f, content=有朋友就是这个病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68606437070, createdName=3079268_9903, createdTime=Sat Jul 16 14:03:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216510, encodeId=29aa121651063, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:13 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215499, encodeId=98581215499a5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Fri Apr 29 07:13:59 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-07-16 3079268_9903

    有朋友就是这个病

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1232794, encodeId=1a7b1232e948f, content=有朋友就是这个病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68606437070, createdName=3079268_9903, createdTime=Sat Jul 16 14:03:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216510, encodeId=29aa121651063, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:13 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215499, encodeId=98581215499a5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Fri Apr 29 07:13:59 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-05-03 1064510_1039
  3. [GetPortalCommentsPageByObjectIdResponse(id=1232794, encodeId=1a7b1232e948f, content=有朋友就是这个病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68606437070, createdName=3079268_9903, createdTime=Sat Jul 16 14:03:40 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216510, encodeId=29aa121651063, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:13 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215499, encodeId=98581215499a5, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>嗯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Fri Apr 29 07:13:59 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-04-29 1064510_1039